The adjuvant activity of Ad-9D9 was confirmed with a second GAd-based multi-epitope vaccine encoding for 62 CD4 and CD8 neo-antigens selected from the CT26 murine colon carcinoma cell line (GAd-62nag). The gene discussed is CD4; the disease is colon carcinoma.